Macrophage Migration Inhibitory Factor (MIF) Plasma Concentration in Critically Ill COVID-19 Patients: A Prospective Observational Study

Mortality in critically ill coronavirus disease 2019 (COVID-19) patients is high and pharmacological treatment strategies remain limited. Early-stage predictive biomarkers are needed to identify patients with a high risk of severe clinical courses and to stratify treatment strategies. Macrophage mig...

Descripción completa

Detalles Bibliográficos
Autores principales: Bleilevens, Christian, Soppert, Josefin, Hoffmann, Adrian, Breuer, Thomas, Bernhagen, Jürgen, Martin, Lukas, Stiehler, Lara, Marx, Gernot, Dreher, Michael, Stoppe, Christian, Simon, Tim-Philipp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922575/
https://www.ncbi.nlm.nih.gov/pubmed/33671433
http://dx.doi.org/10.3390/diagnostics11020332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922575/
https://www.ncbi.nlm.nih.gov/pubmed/33671433
http://dx.doi.org/10.3390/diagnostics11020332

Ejemplares similares